Josh Jacob

Healthcare / Med Tech / Genomics / Health IT / Digital / Analytics / Life Sciences / Pharma / Biotech / Patient Engagement

[Josh Jacob @thejosh111]

@ViewFromTheQ What time would it hit 10,000 you think?

[Josh Jacob @thejosh111]

@nikillinit Syapse Oncology - "Integrates clinical, molecular, treatment, and outcomes data to create a structured, foundational database for the precision medicine program"

[Josh Jacob @thejosh111]

https://t.co/OFnzdIpX5s https://t.co/zjFXpeUv7b

[Josh Jacob @thejosh111]

Jeff Kindler, Former CEO Of Pfizer, On Making Career Decisions, And Healthcare Reform https://t.co/jouie39nVH

[Josh Jacob @thejosh111]

Identifying Opportunities for Innovation - Expertise at GLG https://t.co/QsdBqFXhLw

[Josh Jacob @thejosh111]

GLG Expands London Headquarters With Move to One Fitzroy Place https://t.co/W53cvoJ444

[Josh Jacob @thejosh111]

If it's not broken, break it. https://t.co/iZczlS7Xbm

[Josh Jacob @thejosh111]

GLG in Financial Times https://t.co/IE5DxmWN71

[Josh Jacob @thejosh111]

@scripnews So time has revealed that Allergizer is going ahead! If only they would actually use the name Allergizer...

[Josh Jacob @thejosh111]

PfiZeneca didn't work out. not so sure about Allergizer https://t.co/7opJRhCK8Y

[Scrip, Citeline Commercial @PharmaScrip]

How does 'PfizerGan' compare? Major pharma and biotech M&A deals since 1996 - https://t.co/e9JlixLMWV

[Josh Jacob @thejosh111]

Well hello NY

[Josh Jacob @thejosh111]

@biosimilarz @pfizer @Hospira_Inc It seems that $NVS' Sandoz could also be another viable choice http://t.co/EIx2COnBMa

[Josh Jacob @thejosh111]

@biosimilarz @pfizer @Hospira_Inc $TEVA seems like a sensible choice, since Mylan is already partnered with Biocon. Let's wait and see :)

[Josh Jacob @thejosh111]

With @pfizer receiving EU approval to acquire @Hospira_Inc , its own biosimilar infliximab will be up for grabs. Who will take it?

[Josh Jacob @thejosh111]

From its previous motive in bypassing the NICE tunnel, the Cancer Drugs Fund now has to pay the toll fee http://t.co/GRfXeVInru

[Josh Jacob @thejosh111]

First #PCSK9 inhibitor #repatha to be approved in the world! Good job @Amgen http://t.co/bjSf8hz8uk

[Josh Jacob @thejosh111]

Making savings from European drugs budgets http://t.co/qMXK33Qy1P via @pmlivecom

[Josh Jacob @thejosh111]

@Sermo Poll: 7% of >2,000 doctors say patients should NOT receive unapproved drugs under compassionate use

[Josh Jacob @thejosh111]

Venture Financing Trends in Biotech: A Decade of Healthy Investment Returns https://t.co/FEXNNnLPwu

[Josh Jacob @thejosh111]

Rekindling with Darwin today @NHM_London